1965PubMedRequires access

Long duration of complete remissions in acute leukemia.

Jean François Bernard

Open publisher page 4 citations

Abstract

Reports are presented of 13 cases of acute leukemia in which the patient has survived for more than 4 years. In 12 of these cases, remission was complete for more than 3 years. Seven patients continue in remission and in good general health variously 8 years 6 months, 6 years 7 months (2 patients), 4 years 9 months (2 patients), 4 years 8 months, and 4 years 3 months after the onset of acute leukemia. The variety of forms observed, the relatively high proportion of myeloblastic leukemias, and the diversity and occasional mildness of the therapy applied are evidence in this series in favor of the intervention of the defense mechanisms of the individual patient. The existence of such long-term remissions obtained with proved therapy should be taken into consideration in evaluating the effects of new treatments. Hopes of long-term stabilization of acute leukemias no longer appear completely unreasonable. The aim of all therapy of acute leukemia is to increase the number of patients in long-term remission.

About this research paper

What this paper is about

Reports are presented of 13 cases of acute leukemia in which the patient has survived for more than 4 years. In 12 of these cases, remission was complete for more than 3 years. Seven patients continue in remission and in good general health variously 8 years 6 months, 6 years 7 months (2 patients), 4 years 9 months (2 patients), 4 years 8 months, and 4 years 3 months after the onset of acute leukemia. The variety of forms observed, the relatively high proportion of myeloblastic leukemias, and the diversity and occasional mildness of the therapy applied are evidence in this series in favor of the intervention of the defense mechanisms of the individual patient. The existence of such long-term remissions obtained with proved therapy should be taken into consideration in evaluating the effects of new treatments. Hopes of long-term stabilization of acute leukemias no longer appear completely unreasonable. The aim of all therapy of acute leukemia is to increase the number of patients in long-term remission.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Reports are presented of 13 cases of acute leukemia in which the patient has survived for more than 4 years. In 12 of these cases, remission was complete for more than 3 years. Seven patients continue in remission and in good general health variously 8 years 6 months, 6 years 7 months (2 patients), 4 years 9 months (2 patients), 4 years 8 months, and 4 years 3 months after the onset of acute leukemia. The variety of forms observed, the relatively high proportion of myeloblastic leukemias, and the diversity and occasional mildness of the therapy applied are evidence in this series in favor of the intervention of the defense mechanisms of the individual patient. The existence of such long-term remissions obtained with proved therapy should be taken into consideration in evaluating the effects of new treatments. Hopes of long-term stabilization of acute leukemias no longer appear completely unreasonable. The aim of all therapy of acute leukemia is to increase the number of patients in long-term remission.

Key concepts: Medicine, Complete remission, Acute leukemia, Acute myeloblastic leukemia, Leukemia, Pediatrics, Surgery, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Long duration of complete remissions in acute leukemia. — Research Paper | ScholarLens